Amedisys (AMED) Misses Q3 EPS by 17c
Tweet
Share
E-mail
Get Alerts AMED Hot Sheet
Price: $100.99 --0%
Financial Fact:
Cost of service, excluding depreciation and amortization: 212.12M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Financial Fact:
Cost of service, excluding depreciation and amortization: 212.12M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Amedisys (NASDAQ: AMED) reported Q3 EPS of $1.00, $0.17 worse than the analyst estimate of $1.17. Revenue for the quarter came in at $587.7 million versus the consensus estimate of $589.39 million.
For earnings history and earnings-related data on Amedisys (AMED) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Upgrades China Resources Microelectronics Ltd (688396:CH) to Neutral
- DoorDash (DASH) Reiterated at Market Outperform by Citizens on Channel Connected Launch
- JPMorgan Upgrades SHIFT UP Corp (462870:KS) to Overweight
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
